Skip to search formSkip to main contentSkip to account menu

CEBPA wt Allele

Known as: C/EBP-alpha, CCAAT/Enhancer Binding Protein (C/EBP), Alpha wt Allele, CEBPA 
Human CEBPA wild-type allele is located in the vicinity of 19q13.1 and is approximately 2 kb in length. This allele, which encodes CCAAT/enhancer… 
National Institutes of Health

Related topics

Related topics

11 relations
19q13.1Acute Myeloid Leukemia with Mutated CEBPAAndrogen Receptor Regulation PathwayCCAAT/Enhancer Binding Protein Alpha

Broader (1)

CEBPA gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
CD7在CEBPA野生型和突变型急性髓系白血病患者中的表达及其预后意义
目的 分析CD7在初治急性髓系白血病（AML）患者中的表达和预后价值，进一步探讨CD7表达情况与CEBPA突变的相关性，明确其在CEBPA野生型和突变型AML患者中与预后的关系。 方法 回顾性分析2010年1月至2016年12月收治的298例初治AML… 
2018
2018
Spontaneous adipogenic differentiation potential of adipose‑derived stem cells decreased with increasing cell passages.
Primary adipose-derived stem cells (ADSCs) are a mixture of cell types including preadipocytes having the ability to… 
2015
2015
Caracterización de polimorfismos en los genes PPARG, CEBPA, LIPE, RXRA y FABP4 asociados a metabolismo lipídico en razas de ganado bovino
The meat quality is determined by features such as marbling, flavor, tenderness and composition, among others. These qualities… 
2014
2014
Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome
Recently, the presence of CEBPA mutation was identified as an important prognostic factor for normal karyotype (NK) acute myeloid… 
2014
2014
[Clinical characteristics and therapeutic efficacy of normal karyotype AML patients with CEBPA mutation].
This study was aimed to explore the clinical characteristics and therapeutic efficacy of normal karyotype AML patients with CEBPA… 
2014
2014
Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD.
This study is aimed to investigate the pattern of CEBPA mutations and its clinical significance in Chinese non-M3 acute myeloid… 
Review
2012
Review
2012
Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.
Abstract 2538 Aims: Among acute myeloid leukemia (AML) patients with intermediate-risk cytogenetics, C/EBPa mutations represent a… 
2011
2011
Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts
The percentage of myeloperoxidase (MPO)-positive blast cells is a simple and highly significant prognostic factor in AML patients… 
2006
2006
Identification of a Subgroup of Biphenotypic Myeloid/T-Cell Acute Leukemias with a CEBPA-Mutant Gene Expression Profile, Frequent CEBPA Promoter Hypermethylation and NOTCH1 Mutations.
Recently, gene expression profiling has allowed the identification of specific molecular signatures of established as well as… 
1992
1992
The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1.
The CEBPA gene encoding CCAAT/enhancer binding protein (C/EBP alpha) has been mapped to human chromosome 19 and the CEBPB… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)